Atopic dermatitis: A case report and current clinical review of systemic and ocular manifestations

Optometry

Volumn 72, Issue 2, 2001, Pages 94-102

  Brandonisio, Tina M ^a   Bachman, Jane A ^a   Sears, Joan M ^a  

^a ILLINOIS COLLEGE OF OPTOMETRY   (United States)

Author keywords

Atopic dermatitis; Cataract; Eczema; Keratoconjunctivitis; Pruritis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; EYE DROPS; PREDNISOLONE; PREDNISOLONE 21 PHOSPHATE; TIMOLOL;

ALLERGIC CONJUNCTIVITIS; ATOPIC DERMATITIS; CASE REPORT; CATARACT; CORNEA EDEMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; MIDDLE AGED; PROGNOSIS; REVIEW; VISUAL ACUITY;

ADRENERGIC BETA-ANTAGONISTS; CATARACT; CONJUNCTIVITIS, ALLERGIC; CORNEAL EDEMA; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PREDNISOLONE; PROGNOSIS; TIMOLOL; VISUAL ACUITY;

EID: 0035256435     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Gawkrodger DJ. An illustrated color text of dermatology. London: Churchill Livingstone, 1992.
2. Tuft SJ, Kemeny DM, Dart JKG, et al. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991;98:150-8.
3. Leung DY. Role of IgE in atopic dermatitis. Curr Opin Immunol 1993;5:956-62.
4. Garrity JA, Liesegang TL. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984;19:21-4.
5. Hogan MJ. Atopic keratoconjunctivitis. Trans Am Ophthalmol Soc 1952;50:265-81.
6. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology 1990;97:992-1000.
7. Leung DYM, Rhodes AR, Geah RS. Atopic dermatitis. In: Fitzpatrick TB, et al., eds. Dermatology in general medicine, 3rd ed. New York: McGraw-Hill, 1987:1389.
8. Beethan WP. Atopic cataract. Arch Ophthalmol 1940; 24:21-37.
9. Brunsting LA, Red WB, Bair HL. Occurrence of cataracts and keratoconus with atopic dermatitis. Arch Dermatol 1955;72:237-41.
10. Oshinskie L, Haine C. Atopic dermatitis and its ophthalmic complications. J AM OPTOM ASSOC 1982;53: 889-94.
11. Braude LS, Chandler JW. Atopic corneal disease. Int Ophthalmol Clin 1984;24:145-56.
12. Buckley RJ. Atopic disease of the cornea. In: Cavenagh HD, ed. The cornea: transactions of the World Congress of the Cornea HI. New York: Raven Press, 1988:435-7.
13. Friedlaender MH. Atopic dermatitis and keratoconjunctivitis. In: Mannis MJ, et al., eds. Eye and skin disease. Philadelphia: Lippincott, 1996:149-53.
14. Ruzicka T. Atopic eczema between rationality and irrationality. Arch Dermatol 1998;134:1462-9.
15. Niwa Y, Iizawa O. Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis. Arch Dermatol 1994;130:1387-92.
16. Reeves JRT, Maibach H. Clinical dermatology illustrated: a regional approach. Sydney: Williams & Wilkins, 1986.
17. Foster CS, Rice BA, Dutt JE. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991;98:1190-6.
18. Kanani AS, Sussman GL. The role of infection in atopic dermatitis. J Cutan Med Surg 1999;3(Suppl2):S2-29 through S2-32.
19. Hanifin JM. Recognizing and managing clinical problems in atopic dermatitis. Allergy Proc 1989;10:397-402.
20. Hanifin JM, Lobitz WC Jr. Newer concepts of atopic dermatitis. Arch Dermatol 1977;113:663-70.
21. Uehara M. Infraorbital fold in atopic dermatitis. Arch Dermatol 1981;117:627-9.
22. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-37.
23. Schneider LC, Lester MR. Office pediatrics: atopic disease, rhinitis and conjunctivitis, and upper respiratory infections. Curr Opin Peds 1998;10:539-47.
24. Leung DY. Molecular basis of allergic disease: minireview. Mol Genet Metab 1998;63:157-67.
25. Koro O, Furutani K, Hide M, et al. Chemical mediators in atopic dermatitis: involvement of leukotrience B4 released by a type I allergic reaction in the pathognesis of atopic dermatitis. J Allergy Clin Immunol 1999;103:663-70.
26. Shibaki A. Fc-RI on dendritic cells: a receptor, which links IgE mediated allergic reaction and T cell mediated cellular response. J Dermatol Sci 1998;20:29-38.
27. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5.
28. Sauer GC. Manual of skin diseases. Philadelphia: Lippincott, 1985.
29. Walker C, Craig TJ. Atopic dermatitis: a clinical review for the primary care physician. J Am Osteopath Assoc 1999;99:5-10.
30. Christiansen JV, Gadborg E, Kleiter I, et al. Efficacy of bufexamac (NFN) cream in skin diseases. Dermatologica 1977;154:177-84.
31. Sudilovsky A, Clewe TH. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eczematous dermatoses. J Clin Pharmacol 1975;15:779-84.
32. Yawalkar SJ, Schwerzmann L. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis/ Am Acad Dermatol 1991; 25:1163-6.
33. Nuovo J, Ellsworth AJ, Larson EB. Treatment of atopic dermatitis with antihistamines: lessons from a single-patient, randomized clinical trial. J Am Board Fam Pract 1992;5:137-41.
34. Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines. Drugs 1999;57:31-47.
35. Cooper KD. New therapeutic approach to atopic dermatitis. Clin Rev Allergy. 1993;11:543-59.
36. Noh G, Lee KY. Intravenous immune globulin (IVIG) therapy in steroid-resistant atopic dermatitis. J Korean Med Sci 1999;14:63-8.
37. Sugimoto K, Kuroki H, Kanazawa M, et al. New successful treatment with disinfectant for atopic dermatitis. Dermatology 1997;195(Suppl2):62-8.
38. Yoshimura-Mishima M, Akamatsu H, Namura S, et al. Suppressive effect of ultraviolet (UVB and PUVA) radiation on superantigen production of Staphylococcus aureus. J Dermatol Sci 1999;19:31-6.
39. Buckley DA, Baldwin P, Rogers S. The use of azathioprine in severe adult atopic eczema. J Eur Acad Dermatol Venereol 1998;11:137-40.
40. Boguniewicz M, Fiedler VC, Raimer S, et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998;102:637-44.
41. Bieber T. Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. J Allergy Clin Immunol 1998;102:555-7.
42. Noren P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol 1989;121:359-66.
43. Regenbogen L, Coscas G, Debbasch S. Oculocutaneous Syndromes. MPS 1988;11:14-28.
44. Katsura H, Hida T. Retinal detachment associated with atopic dermatitis. Retina 1984;4:148-51.
45. Easty D, Enstwistle C, Funk A, et al. Herpes simplex keratitis and keratoconus in the atopic patient: A clinical and immunologic study. Trans Ophthal Soc UK 1975;95:267-76.
46. Toshitani A, Imayama S, Shimozono Y, et al. Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis. J Dermatol Sci 1999; 19:134-8.
47. Smolin G, O'Connor GR. Ocular immunology. Boston: Little, Brown , 1986:171-9.
48. Crowley LV. An introduction to clinical embryology. Chicago: Year Book Medical, 1974.
49. Yoneda K, Okamoto H, Wada Y, et al. Atopic retinal detachment. Report of four cases and a review of the literature. Br J Dermatol 1995;133:586-91.